The Covid-19 pandemic has driven the growth of the global Covid-19 Rapid Antigen Test market, which was valued at USD 5.96 billion in 2022 and is expected to have a revenue compound annual growth rate (CAGR) of 6% over the forecast period, according to a recent report by Reports and Data. The market growth is attributed to the increased demand for fast antigen tests due to their simplicity,...